gefitinib
PolandDrugs containing this active substance
-
The medicine is intended for the treatment of adult patients with non-small cell lung cancer.
Form: tablets, film-coated
Active substance Dosage gefitinib 250 mg ATC: L01EB01
Manufacturer: Laboratori FUNDACIO DAU Pharmadox Healthcare Ltd. Wessling Hungary Ltd.
-
The medicine is used in adult patients for the treatment of non-small cell lung cancer.
Form: tablets, film-coated
Active substance Dosage gefitinib 250 mg ATC: L01EB01
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of non-small cell lung cancer.
Form: tablets, film-coated
Active substance Dosage gefitinib 250 mg ATC: L01EB01
Manufacturer: LEK Pharmaceuticals d.d. Remedica Ltd
-
It is used in adult patients for the treatment of non-small cell lung cancer.
Form: tablets, film-coated
Active substance Dosage gefitinib 250 mg ATC: L01XE02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of non-small cell lung cancer.
Form: tablets, film-coated
Active substance Dosage gefitinib 250 mg ATC: L01EB01
Manufacturer: Pharmadox Healthcare Ltd. S.C. Labormed-Pharma S.A.